TechCare Trauma | Fracture and elbow joint effusion detection | USA

FDA | MSK, Pediatric & Emergency | X-ray | Amplifier Partner

Description of use

TechCare Trauma raises the quality of care while making readers more productive. In its FDA reader study, readers' sensitivity for fractures rose by 22% in adults and 20% in children, and reading time was 24% shorter in adults. As of 2026, it is the only FDA-cleared fracture AI from birth, depending on the body region, and was the first to include elbow joint effusion, from age 2. Standalone ROC-AUC is above 0.96 in adults and children. It covers the limbs, shoulder, clavicle, pelvis and hip, and the ribs in adults. Each suspected finding is boxed and labeled YES or DOUBT, and exams with a suspected fracture can move up the IDS7 worklist. TechCare Trauma, developed by Milvue, is FDA 510(k) cleared (K242171) as a Class II device (21 CFR 892.2090). Rx only. See IFU and 510(k) summary.

The application content is provided by the respective AI vendors.